CD34 and central nervous system cancer: After calculating the correlations among the expression levels of HULC, VEGF, ESM-1 and MVD (CD34), we observed a significant linear correlation between HULC, VEGF, ESM-1 and MVD (CD34) in primary glioma patient pathological tissue (Figure 1C–1E).